Celldex Therapeutics, Inc.-Product Pipeline Review-2015

Celldex Therapeutics, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07101CDB
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Celldex Therapeutics, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Celldex Therapeutics, Inc.-Product Pipeline Review-2015', provides an overview of the Celldex Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celldex Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Celldex Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Celldex Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Celldex Therapeutics, Inc.'s pipeline products

Reasons To Buy

Evaluate Celldex Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Celldex Therapeutics, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Celldex Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Celldex Therapeutics, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celldex Therapeutics, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Celldex Therapeutics, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Celldex Therapeutics, Inc. Snapshot 5

Celldex Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

Celldex Therapeutics, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Celldex Therapeutics, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Celldex Therapeutics, Inc.-Pipeline Products Glance 12

Celldex Therapeutics, Inc.-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Celldex Therapeutics, Inc.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Celldex Therapeutics, Inc.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Celldex Therapeutics, Inc.-Unknown Stage Pipeline Products 16

Unknown Products/Combination Treatment Modalities 16

Celldex Therapeutics, Inc.-Drug Profiles 17

rindopepimut 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

CDX-1401 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

CDX-301 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

glembatumumab vedotin 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

varlilumab 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

CDX-1135 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

CDX-2401 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

CDX-014 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Celldex Therapeutics, Inc.-Pipeline Analysis 31

Celldex Therapeutics, Inc.-Pipeline Products by Target 31

Celldex Therapeutics, Inc.-Pipeline Products by Molecule Type 32

Celldex Therapeutics, Inc.-Pipeline Products by Mechanism of Action 33

Celldex Therapeutics, Inc.-Recent Pipeline Updates 34

Celldex Therapeutics, Inc.-Dormant Projects 45

Celldex Therapeutics, Inc.-Discontinued Pipeline Products 46

Discontinued Pipeline Product Profiles 46

CDX-1135 46

Celldex Therapeutics, Inc.-Company Statement 47

Celldex Therapeutics, Inc.-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Celldex Therapeutics, Inc.-Key Manufacturing Facilities 49

Appendix 50

Methodology 50

Coverage 50

Secondary Research 50

Primary Research 50

Expert Panel Validation 50

Contact Us 50

Disclaimer 51

List of Tables

Celldex Therapeutics, Inc., Key Information 5

Celldex Therapeutics, Inc., Key Facts 5

Celldex Therapeutics, Inc.-Pipeline by Indication, 2015 6

Celldex Therapeutics, Inc.-Pipeline by Stage of Development, 2015 8

Celldex Therapeutics, Inc.-Monotherapy Products in Pipeline, 2015 9

Celldex Therapeutics, Inc.-Partnered Products in Pipeline, 2015 10

Celldex Therapeutics, Inc.-Partnered Products/ Combination Treatment Modalities, 2015 11

Celldex Therapeutics, Inc.-Phase III, 2015 12

Celldex Therapeutics, Inc.-Phase II, 2015 13

Celldex Therapeutics, Inc.-Phase I, 2015 14

Celldex Therapeutics, Inc.-Preclinical, 2015 15

Celldex Therapeutics, Inc.-Unknown, 2015 16

Celldex Therapeutics, Inc.-Pipeline by Target, 2015 31

Celldex Therapeutics, Inc.-Pipeline by Molecule Type, 2015 32

Celldex Therapeutics, Inc.-Pipeline Products by Mechanism of Action, 2015 33

Celldex Therapeutics, Inc.-Recent Pipeline Updates, 2015 34

Celldex Therapeutics, Inc.-Dormant Developmental Projects,2015 45

Celldex Therapeutics, Inc.-Discontinued Pipeline Products, 2015 46

Celldex Therapeutics, Inc., Other Locations 49

Celldex Therapeutics, Inc., Key Manufacturing Facilities 49

List of Figures

Celldex Therapeutics, Inc.-Pipeline by Top 10 Indication, 2015 6

Celldex Therapeutics, Inc.-Pipeline by Stage of Development, 2015 8

Celldex Therapeutics, Inc.-Monotherapy Products in Pipeline, 2015 9

Celldex Therapeutics, Inc.-Pipeline by Top 10 Target, 2015 31

Celldex Therapeutics, Inc.-Pipeline by Top 10 Molecule Type, 2015 32

Celldex Therapeutics, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Celldex Therapeutics, Inc.; Celldex Therapeutics, Inc. - Key Therapeutics; Celldex Therapeutics, Inc. - Pipeline Overview and Promising Molecules; Celldex Therapeutics, Inc. - News; Celldex Therapeutics, Inc. - Latest Updates; Celldex Therapeutics, Inc. - Pipeline; Celldex Therapeutics, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 102135
Site License
USD 3000 INR 204270
Corporate User License
USD 4500 INR 306405



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com